Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy
- Algoritmes
- Behandeling op maat
- Betaaltitel
- Biomarker
- cfDNA
- DNA
- Educatie
- Geen onderdeel van een categorie
- GENAYA project
- Hartwig Medical Database
- Hartwig Medical Foundation
- Hergebruik data
- Innovatie
- IT
- Kwaliteit
- Lab proces
- Lerend zorgsysteem
- Medicijn
- Moleculaire diagnostiek
- OncoAct
- oncoanalyser
- OncoAnalyser Dx
- Onderzoek
- Participerende ziekenhuizen
- Pipeline
- Preventie
- Primaire Tumor Onbekend
- Uitbehandeld
- Verhalen patiënten
- Werken in de cloud
- Wetenschappelijke publicaties
- Whole genome sequencing
- Zeldzame kankers
Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy
Maarten J. Van Der Doelen, Niven Mehra, Inge M. Van Oort, Monika G. Looijen-Salamon, Marcel J.R. Janssen, José A.E. Custers, …
Network-Based Analysis to Identify Drivers of Metastatic Prostate Cancer Using GoNetic
Louise De Schaetzen Van Brienen, Giles Miclotte, Maarten Larmuseau, Jimmy Van Den Eynden & Kathleen Marchal Cancers, 2021, DOI
11-Ketotestosterone: the resilience of a potent androgen in prostate cancer patients after castration
Gido Snaterse, Lisanne F. Van Dessel, Job Van Riet, Angela E. Taylor, Michelle Van Der Vlugt-Daane, Paul Hamberg, Ronald De …
Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells
Lisanne Mout, Lisanne F. Van Dessel, Jaco Kraan, Anouk C. De Jong, Rui P.L. Neves, Sigrun Erkens-Schulze, Corine M. Beaufort, …
Predicting patient response with models trained on cell lines and patient-derived xenografts by nonlinear transfer learning
Soufiane M. C. Mourragui, Marco Loog, Daniel J. Vis, Kat Moore, Anna G. Manjon, Mark A. Van De Wiel, Marcel …
The evolution of hematopoietic cells under cancer therapy
Oriol Pich, Albert Cortes-Bullich, Ferran Muiños, Marta Pratcorona, Abel Gonzalez-Perez & Nuria Lopez-Bigas Nature Communications, 2021, DOI
In silico saturation mutagenesis of cancer genes
Ferran Muiños, Francisco Martínez-Jiménez, Oriol Pich, Abel Gonzalez-Perez & Nuria Lopez-Bigas Nature, 2021, DOI
Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types
Hanneke Van Der Wijngaart, Louisa R. Hoes, J. Maxime Van Berge Henegouwen, Daphne L. Van Der Velden, Laurien J. Zeverijn, …
The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets
Job Van Riet, Harmen J. G. Van De Werken, Edwin Cuppen, Ferry A. L. M. Eskens, Margot Tesselaar, Linde M. …
Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing
Clémence T. B. Pasmans, Bastiaan B. J. Tops, Elisabeth M. P. Steeghs, Veerle M. H. Coupé, Katrien Grünberg, Eiko K …
Predicting pathogenic non-coding SVs disrupting the 3D genome in 1646 whole cancer genomes using multiple instance learning
Marleen M. Nieboer, Luan Nguyen & Jeroen De Ridder Scientific Reports, 2021, DOI
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer
Teodora Radonic, W.R.R. Geurts-Giele, Kris G. Samsom, Guido M.J. M. Roemen, Jan H. Von Der Thüsen, Erik Thunnissen, Isabelle C. …
Gepersonaliseerde selectie van experimentele behandeling bij patiënten met gevorderde solide kanker is mogelijk met behulp van whole genome sequencing.